Last updated: 28 April 2026
These terms govern your use of the Damgaard Group website (damgaardgroup.com) and any related services. By using this website, you agree to these terms. If you do not agree, please do not use the website.
This website is operated by:
Damgaard Group ApS
Kildehøjvej 16A
3460 Birkerød, Denmark
CVR: [insert CVR number]
Email: kontor@damgaardgroup.com
Phone: +45 45 82 82 82
Damgaard Group is a Danish pharmaceutical engineering holding company operating two specialist entities: Damgaard Solutions (GMP engineering consultancy) and Catalyst Reactivate (H₂O₂ catalyst reactivation service).
You may use this website for lawful, informational purposes related to our pharmaceutical engineering services. You agree not to:
All content on this website — including text, graphics, logos, images, design, and arrangement — is the property of Damgaard Group ApS or used with permission, and is protected by Danish, EU, and international intellectual property laws.
The names "Damgaard Group", "Damgaard Solutions", "Catalyst Reactivate", and associated logos are trademarks of Damgaard Group ApS. Third-party trademarks (such as client logos shown on this website) remain the property of their respective owners and are used with permission or under fair use principles for descriptive purposes.
You may view, download, and print content for personal or internal business reference purposes. Any other use, including reproduction, modification, distribution, or republication, requires our prior written consent.
This website is informational. Submitting an enquiry through our forms does not create a binding agreement for services. Any engagement with Damgaard Group, Damgaard Solutions, or Catalyst Reactivate is governed by a separate written contract executed between the parties.
We aim to respond to enquiries within one business day. Response times do not constitute a guarantee. We reserve the right to decline enquiries that fall outside our scope of services or where engagement would create a conflict of interest.
Information submitted through our enquiry forms is treated as confidential. We do not share enquiry details with third parties except as necessary to respond to your request, where consent is provided, or where required by law. Where you mark an enquiry as confidential, additional handling protocols apply.
For enquiries involving sensitive technical or commercial information, we recommend executing a Non-Disclosure Agreement (NDA) before substantive discussions. Contact us to request a standard NDA template.
Damgaard Group provides pharmaceutical engineering services in alignment with European GMP standards and supports clients in achieving compliance with FDA, EMA, SFDA expectations and leading pharmacopoeias. Damgaard Group does not claim agency over regulatory approvals. Final regulatory approvals are the responsibility of the relevant manufacturer and the issuing regulatory authority.
Information on this website regarding regulatory frameworks, standards, and pharmacopoeias is provided for general guidance only and should not be relied upon as legal or regulatory advice. Clients should consult qualified regulatory professionals for project-specific guidance.
To the maximum extent permitted by Danish law:
This limitation does not apply to liability arising from gross negligence, intentional misconduct, or any other liability that cannot be limited or excluded under applicable Danish law.
Our website may include links to third-party websites, including Damgaard Solutions (damgaard-solutions.com) and Catalyst Reactivate (catalystreactivate.com). These linked sites are operated by separate entities within the Damgaard Group structure or by independent third parties.
We are not responsible for the content, privacy practices, or terms of third-party sites. Linking to a third-party site does not constitute endorsement of its content or practices.
Our handling of personal data is governed by our Privacy Policy and the EU General Data Protection Regulation (GDPR). Cookie usage is governed by our Cookie Policy.
We may update these terms from time to time to reflect changes in our practices, services, or legal requirements. The "Last updated" date at the top of these terms indicates the most recent revision. Continued use of the website after changes constitutes acceptance of the updated terms.
These terms are governed by Danish law, without regard to conflict of law principles. Any disputes arising from these terms or your use of the website shall be subject to the exclusive jurisdiction of the Danish courts, with venue in the city court (Byretten) located in the jurisdiction of Damgaard Group's registered office.
If any provision of these terms is found to be unenforceable, the remaining provisions will continue in full force and effect.
For questions about these terms or any aspect of our website or services, contact:
Damgaard Group ApS
Kildehøjvej 16A
3460 Birkerød, Denmark
Email: kontor@damgaardgroup.com
Phone: +45 45 82 82 82
Note: These terms describe general practices governing your use of the Damgaard Group website. They are subject to applicable Danish and EU law. For specific legal advice, please consult a qualified Danish attorney. The CVR number placeholder above should be filled in with the correct registration number before public use.
Danish pharmaceutical engineering group. GMP consultancy and H₂O₂ catalyst reactivation for European and global manufacturers.
We support clients in achieving compliance with FDA, EMA, SFDA expectations and leading pharmacopoeias. Damgaard Group does not claim agency over regulatory approvals.